← Back to Search

Community Health Worker Support for Cancer Survivorship

N/A

Recruiting

Led By Hannah Arem, PhD

Research Sponsored by Medstar Health Research Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Diagnosis of stage I-III breast or prostate cancer and completed curative treatment (surgery, radiation, chemotherapy) or finalized treatment plan (e.g. watch and wait)

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

No Placebo-Only Group

Summary

This trial will help to figure out the best way to provide social risk screening and referral services to cancer survivors in order to improve their quality of life.

Who is the study for?

This trial is for Black or African American individuals who have been diagnosed with stage I-III breast or prostate cancer and completed curative treatment, or those with stage IV of these cancers about 6 months post-diagnosis.

What is being tested?

The study aims to improve health and well-being for cancer survivors by screening social risk factors, referring them to community resources, providing Community Health Worker support, and implementing anti-racism training for healthcare staff.

What are the potential side effects?

Since the intervention involves non-medical support rather than drugs or medical procedures, traditional side effects are not expected. However, participants may experience varying levels of emotional impact.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have completed treatment for stage I-III breast or prostate cancer.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Acceptability of the CHW intervention

Appropriateness of the CHW intervention

Feasibility of the CHW intervention

+4 more

Secondary study objectives

Social risk factors

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Intervention participantsExperimental Treatment1 Intervention

Among patients who completed the social needs screening as a part of standard of care, all stage I-IV Black cancer survivors will be invited to participate in a six-month community health worker intervention. The community health worker will assess social needs and provide six months of support.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Community Health Worker support

2008

N/A

~370

0 / 1Eligibility criteria met